Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...
The PTEN-PI3K-AKT pathway is among the most frequently dysregulated oncogenic pathways in metastatic castration-resistant prostate cancer (mCRPC). Multiple inhibitors of this pathway are in late-phase ...
Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy A next-generation sequencing–based cfDNA assay was used to profile 231 patients with mCRPC from ...
Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...
Survey of palliative care use in primary malignant bone tumors: An NCDB review. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text ...
Genomic profiling revealed druggable targets in 39% of advanced prostate cancer cases, guiding personalised treatments.
Hosted on MSN
Colon cancer: THIS common over-the-counter medication slashes risk of colorectal cancer recurrence in half
Imagine popping an over-the-counter pill to remedy a headache. Or taking the same to treat inflammation or arthritis. And all the while, the same common pill is working to cut the risk of colon cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback